Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021)
Nu-Med Plus (NUMD) Total Debt Growth (1y) (2012 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 15.70% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 19.06% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -5.48% |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -92.06% |
| Dec 31, 2020 | -91.79% |
| Sep 30, 2020 | 4,170.48% |
| Jun 30, 2020 | 2,016.51% |
| Mar 31, 2020 | 1,304.92% |
| Dec 31, 2019 | 421.17% |
| Sep 30, 2019 | -78.00% |
| Jun 30, 2019 | -63.35% |
| Mar 31, 2019 | -52.92% |
| Dec 31, 2018 | 9.78% |
| Sep 30, 2018 | -39.07% |
| Jun 30, 2018 | -34.24% |
| Dec 31, 2012 | 2,164.71% |